5 Trends influencing drug pricing
During her presidential campaign, Hillary Clinton brought Turing Pharmaceuticals’ overnight price hike for Daraprim into the spotlight, implying that drug pricing could soon be a main target for healthcare reforms. In response, drugmakers have adopted a few strategies such as pledging to keep annual price increases below 10% or offering greater price transparency.
With no permanent solution in sight, 5 key trends are currently influencing drug pricing decisions:
1. Targeted legislation
2. New models
3. Rare disease and specialty drug development
4. Negotiating power
5. High-deductible insurance plans
